COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study

BACKGROUND: Ipratropium bromide/albuterol Respimat inhaler (CVT-R) was developed as an environmentally friendly alternative to ipratropium bromide/albuterol metered-dose inhaler (CVT-MDI), which uses a chlorofluorocarbon propellant. OBJECTIVE: The objective of this study was to evaluate patient sati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Gary T, Ghafouri, Mo, Dai, Luyan, Dunn, Leonard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607534/
https://www.ncbi.nlm.nih.gov/pubmed/23658479
http://dx.doi.org/10.2147/COPD.S38577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607534/
https://www.ncbi.nlm.nih.gov/pubmed/23658479
http://dx.doi.org/10.2147/COPD.S38577

Ejemplares similares